Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy. - Wikidata - awgldk - TriplyDB

Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy.

Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy.

http://www.wikidata.org/entity/Q40605824

about

Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis Ribavirin monotherapy for chronic hepatitis C Ribavirin plus interferon versus interferon for chronic hepatitis C Wide range of quasispecies diversity during primary hepatitis C virus infection Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte function Viral Determinants of Resistance to Treatment in Patients with Hepatitis C Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials.Effect of ribavirin alone or combined with silymarin on carbon tetrachloride induced hepatic damage in rats.Current and emerging therapeutic approaches to hepatitis C infection.Managing pediatric hepatitis C: current and emerging treatment options.Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA.Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir-containing regimens.Mechanism of action of ribavirin in anti-HCV regimens: new insights for an age-old question?Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring

P2860

Q21132564-B832DE7C-8EDB-4B6C-AB50-AC1A3349E525 Q24240057-91558A57-E7F9-42C2-8DFD-4AE1D2A428C7 Q24240879-D91E4759-B082-4439-BD01-AC75D0C21FBB Q27469430-D1508498-80AD-4EE9-AF6B-19F977173FBE Q27473359-5234D1CF-5AD7-408A-A2C2-9A968C6B8687 Q27478062-1FFC4E25-53AC-4DF9-B546-9F6FFC73FD45 Q27490650-E43F14E5-6D95-480E-9C20-EA9D0CA96611 Q33234511-07F6262C-F3C3-4BD6-80D9-E5737D80BCFF Q35161778-33BA5351-E18A-45C5-99DB-0972C3E65EDD Q35917244-A1490A54-838D-4CAC-9D7C-DC7B36F0F0D5 Q37316248-C78F003C-FAFA-483E-A865-5846389A111A Q40500808-1852A197-BCC0-48F4-BB7B-42AFE0C4EDB0 Q41156164-32F9ACEA-068F-4F03-A921-9C24C7255ADA Q45325188-DB219C05-CCD5-42B1-A7EC-E18FDC1B9DED Q50548636-B5AF9CFF-A45A-4D51-855A-131F14BCC1CA Q59049605-49E0CEF7-BB25-40A8-96FA-1CD39F8FA668

P2860

Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy.

http://www.wikidata.org/entity/Q40605824

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Evolution of hepatitis C virus ...... ceiving ribavirin monotherapy.

@en

type

label

Evolution of hepatitis C virus ...... ceiving ribavirin monotherapy.

@en

prefLabel

Evolution of hepatitis C virus ...... ceiving ribavirin monotherapy.

@en

P1433

Q40605824-E8CDD76C-45CF-4433-AD32-E93A3FC39CF8

P1476

Q40605824-6B82D8CD-BFB9-47B4-A4CB-D13F16099DB6

P2093

Q40605824-27CF428B-4344-4868-AE3A-4BFE47CC4623

Q40605824-A689A528-927A-410E-A3DB-CBB1261B932E

Q40605824-C656B28C-DAC5-4ABB-B9DB-F8920E2D9D40

Q40605824-C8DB982D-AF53-48C5-95D6-CF4251FE38BE

Q40605824-DE02A879-1B91-4D19-9D91-A12B3DA2A655

Q40605824-E0049789-8829-44F2-9C3F-409362AA5F80

P2860

Q40605824-018BF02B-DCF6-4721-93F9-368E1F9EAA6F

Q40605824-031BD12F-0ED9-4471-933E-EC386EDF6794

Q40605824-0B23AD2A-2075-4C32-B032-13D419F9A984

Q40605824-0C9DD9E0-C6D3-45E2-B653-7D69F129968B

Q40605824-1BEEC42B-2A7B-4E34-B489-01ACA6A3E5C8

Q40605824-1F2B5D23-83E9-4002-9C3C-9FF65D78A195

Q40605824-2D950F32-DFA4-4F2D-AFCF-AB919C53A316

Q40605824-2EAE1BD9-730F-4BA2-856D-2B7AAEFDFFC3

Q40605824-2F92B012-C19A-4407-A05E-840CBC29EB08

Q40605824-3F3206FA-75F3-4045-AFC3-AFE20112F9B3

P304

Q40605824-DC881833-2738-4FD7-B116-A6B61D49B776

P31

Q40605824-D97667AD-55CF-4AFF-A822-E1598EE4F7A8

P356

Q40605824-E999543F-8D77-4093-A543-FA78A973498C

P433

Q40605824-EFC0E6D8-9441-45B7-AFA2-8423D87E60FF

P478

Q40605824-159804D3-9845-47D5-B9AC-6C11D8EC5347

P577

Q40605824-331E9214-DAFA-43F9-ACE0-8A11AFF6AC14

P698

Q40605824-9D0E0D5F-4DFE-4094-B0DD-784863A33B16

P356

J.1365-2893.2001.00265.X

P1433

Journal of Viral Hepatitis

P1476

Evolution of hepatitis C virus ...... ceiving ribavirin monotherapy.

@en

P2093

Billaud G

http://www.w3.org/2001/XMLSchema#string

Maertens G

http://www.w3.org/2001/XMLSchema#string

Querenghi F

http://www.w3.org/2001/XMLSchema#string

Trépo C

http://www.w3.org/2001/XMLSchema#string

Yu Q

http://www.w3.org/2001/XMLSchema#string

Zoulim F

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.

Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure

A pilot study of ribavirin therapy for chronic hepatitis C

The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

P304

120-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2893.2001.00265.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11264732

http://www.w3.org/2001/XMLSchema#string